The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Controlled drug delivery is one which delivers the drug at a predetermined rate, for locally or systemically, for a specified period of time.
The global Controlled Release Drug Delivery market was valued at US$ 43280 million in 2023 and is anticipated to reach US$ 74320 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Controlled Release Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Controlled Release Drug Delivery.
Report Scope
The Controlled Release Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Controlled Release Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Controlled Release Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Depomed
- Coating Place
- Corium
- Johnson and Johnson
- Alkermes
- Pfizer
- Orbis Biosciences
- Capsugel
- Merck
- Aradigm
Segment by Type
- Wurster Technique
- Coacervation
- Micro Encapsulation
- Implants
- Transdermal
- Targeted Delivery
- Others
Segment by Application
- Metered Dose Inhalers
- Injectables
- Transdermal and Ocular Patches
- Infusion Pumps
- Oral Controlled-Drug Delivery Systems
- Drug Eluting Stents
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Controlled Release Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Controlled Release Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Wurster Technique
1.2.3 Coacervation
1.2.4 Micro Encapsulation
1.2.5 Implants
1.2.6 Transdermal
1.2.7 Targeted Delivery
1.2.8 Others
1.3 Market by Application
1.3.1 Global Controlled Release Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Metered Dose Inhalers
1.3.3 Injectables
1.3.4 Transdermal and Ocular Patches
1.3.5 Infusion Pumps
1.3.6 Oral Controlled-Drug Delivery Systems
1.3.7 Drug Eluting Stents
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Controlled Release Drug Delivery Market Perspective (2019-2030)
2.2 Controlled Release Drug Delivery Growth Trends by Region
2.2.1 Global Controlled Release Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Controlled Release Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Controlled Release Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Controlled Release Drug Delivery Market Dynamics
2.3.1 Controlled Release Drug Delivery Industry Trends
2.3.2 Controlled Release Drug Delivery Market Drivers
2.3.3 Controlled Release Drug Delivery Market Challenges
2.3.4 Controlled Release Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Controlled Release Drug Delivery Players by Revenue
3.1.1 Global Top Controlled Release Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Controlled Release Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Controlled Release Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Controlled Release Drug Delivery Revenue
3.4 Global Controlled Release Drug Delivery Market Concentration Ratio
3.4.1 Global Controlled Release Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Controlled Release Drug Delivery Revenue in 2023
3.5 Controlled Release Drug Delivery Key Players Head office and Area Served
3.6 Key Players Controlled Release Drug Delivery Product Solution and Service
3.7 Date of Enter into Controlled Release Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Controlled Release Drug Delivery Breakdown Data by Type
4.1 Global Controlled Release Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Controlled Release Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Controlled Release Drug Delivery Breakdown Data by Application
5.1 Global Controlled Release Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Controlled Release Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Controlled Release Drug Delivery Market Size (2019-2030)
6.2 North America Controlled Release Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Controlled Release Drug Delivery Market Size by Country (2019-2024)
6.4 North America Controlled Release Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Controlled Release Drug Delivery Market Size (2019-2030)
7.2 Europe Controlled Release Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Controlled Release Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Controlled Release Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Controlled Release Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Controlled Release Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Controlled Release Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Controlled Release Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Controlled Release Drug Delivery Market Size (2019-2030)
9.2 Latin America Controlled Release Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Controlled Release Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Controlled Release Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Controlled Release Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Controlled Release Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Controlled Release Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Controlled Release Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Depomed
11.1.1 Depomed Company Detail
11.1.2 Depomed Business Overview
11.1.3 Depomed Controlled Release Drug Delivery Introduction
11.1.4 Depomed Revenue in Controlled Release Drug Delivery Business (2019-2024)
11.1.5 Depomed Recent Development
11.2 Coating Place
11.2.1 Coating Place Company Detail
11.2.2 Coating Place Business Overview
11.2.3 Coating Place Controlled Release Drug Delivery Introduction
11.2.4 Coating Place Revenue in Controlled Release Drug Delivery Business (2019-2024)
11.2.5 Coating Place Recent Development
11.3 Corium
11.3.1 Corium Company Detail
11.3.2 Corium Business Overview
11.3.3 Corium Controlled Release Drug Delivery Introduction
11.3.4 Corium Revenue in Controlled Release Drug Delivery Business (2019-2024)
11.3.5 Corium Recent Development
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Company Detail
11.4.2 Johnson and Johnson Business Overview
11.4.3 Johnson and Johnson Controlled Release Drug Delivery Introduction
11.4.4 Johnson and Johnson Revenue in Controlled Release Drug Delivery Business (2019-2024)
11.4.5 Johnson and Johnson Recent Development
11.5 Alkermes
11.5.1 Alkermes Company Detail
11.5.2 Alkermes Business Overview
11.5.3 Alkermes Controlled Release Drug Delivery Introduction
11.5.4 Alkermes Revenue in Controlled Release Drug Delivery Business (2019-2024)
11.5.5 Alkermes Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Controlled Release Drug Delivery Introduction
11.6.4 Pfizer Revenue in Controlled Release Drug Delivery Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Orbis Biosciences
11.7.1 Orbis Biosciences Company Detail
11.7.2 Orbis Biosciences Business Overview
11.7.3 Orbis Biosciences Controlled Release Drug Delivery Introduction
11.7.4 Orbis Biosciences Revenue in Controlled Release Drug Delivery Business (2019-2024)
11.7.5 Orbis Biosciences Recent Development
11.8 Capsugel
11.8.1 Capsugel Company Detail
11.8.2 Capsugel Business Overview
11.8.3 Capsugel Controlled Release Drug Delivery Introduction
11.8.4 Capsugel Revenue in Controlled Release Drug Delivery Business (2019-2024)
11.8.5 Capsugel Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Controlled Release Drug Delivery Introduction
11.9.4 Merck Revenue in Controlled Release Drug Delivery Business (2019-2024)
11.9.5 Merck Recent Development
11.10 Aradigm
11.10.1 Aradigm Company Detail
11.10.2 Aradigm Business Overview
11.10.3 Aradigm Controlled Release Drug Delivery Introduction
11.10.4 Aradigm Revenue in Controlled Release Drug Delivery Business (2019-2024)
11.10.5 Aradigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
